Your browser doesn't support javascript.
loading
Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation.
Xu, Ting; Yu, Weiwei; Fang, Hui; Wang, Zhen; Chi, Zhexu; Guo, Xingchen; Jiang, Danlu; Zhang, Kailian; Chen, Sheng; Li, Mobai; Guo, Yuxian; Zhang, Jian; Yang, Dehang; Yu, Qianzhou; Wang, Di; Zhang, Xue.
Afiliação
  • Xu T; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Yu W; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Fang H; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Wang Z; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Chi Z; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Guo X; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, 430072, Wuhan, P.R. China.
  • Jiang D; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Zhang K; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Chen S; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Li M; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Guo Y; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Zhang J; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Yang D; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Yu Q; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China.
  • Wang D; Institute of Immunology and Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, P.R. China. diwang@zju.edu.cn.
  • Zhang X; Liangzhu Laboratory, Zhejiang University Medical Center, 311121, Hangzhou, P.R. China. diwang@zju.edu.cn.
Cell Death Differ ; 29(8): 1582-1595, 2022 08.
Article em En | MEDLINE | ID: mdl-35110683
ABSTRACT
The NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome plays a pivotal role in defending the host against infection as well as sterile inflammation. Activation of the NLRP3 inflammasome is critically regulated by a de-ubiquitination mechanism, but little is known about how ubiquitination restrains NLRP3 activity. Here, we showed that the membrane-bound E3 ubiquitin ligase gp78 mediated mixed ubiquitination of NLRP3, which inhibited NLRP3 inflammasome activation by suppressing the oligomerization and subcellular translocation of NLRP3. In addition, the endoplasmic reticulum membrane protein insulin-induced gene 1 (Insig-1) was required for this gp78-NLRP3 interaction and gp78-mediated NLRP3 ubiquitination. gp78 or Insig-1 deficiency in myeloid cells led to exacerbated NLRP3 inflammasome-dependent inflammation in vivo, including lipopolysaccharide-induced systemic inflammation and alum-induced peritonitis. Taken together, our study identifies gp78-mediated NLRP3 ubiquitination as a regulatory mechanism that restrains inflammasome activation and highlights NLRP3 ubiquitination as a potential therapeutic target for inflammatory diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article